IN2012DN03379A - - Google Patents

Download PDF

Info

Publication number
IN2012DN03379A
IN2012DN03379A IN3379DEN2012A IN2012DN03379A IN 2012DN03379 A IN2012DN03379 A IN 2012DN03379A IN 3379DEN2012 A IN3379DEN2012 A IN 3379DEN2012A IN 2012DN03379 A IN2012DN03379 A IN 2012DN03379A
Authority
IN
India
Prior art keywords
present
spore
relates
coated
vaccine
Prior art date
Application number
Other languages
English (en)
Inventor
Simon Michael Cutting
Hong Anh Huynh
Original Assignee
New Royal Holloway & Bedford
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New Royal Holloway & Bedford filed Critical New Royal Holloway & Bedford
Publication of IN2012DN03379A publication Critical patent/IN2012DN03379A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/07—Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IN3379DEN2012 2009-09-21 2010-09-21 IN2012DN03379A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0916570.5A GB0916570D0 (en) 2009-09-21 2009-09-21 Method
PCT/GB2010/001771 WO2011033275A1 (en) 2009-09-21 2010-09-21 Bacterial spore having therapeutic agent adsorbed on its surface

Publications (1)

Publication Number Publication Date
IN2012DN03379A true IN2012DN03379A (ja) 2015-10-23

Family

ID=41278080

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3379DEN2012 IN2012DN03379A (ja) 2009-09-21 2010-09-21

Country Status (6)

Country Link
US (1) US8673311B2 (ja)
EP (1) EP2480241A1 (ja)
CN (1) CN102630163A (ja)
GB (1) GB0916570D0 (ja)
IN (1) IN2012DN03379A (ja)
WO (1) WO2011033275A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8932598B2 (en) * 2012-08-28 2015-01-13 Vaxinnate Corporation Fusion proteins and methods of use
US9845342B2 (en) 2014-09-17 2017-12-19 Spogen Biotech Inc. Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria
WO2021055474A1 (en) * 2019-09-16 2021-03-25 Microbiome Labs, Llc Spore-based probiotic supplementation in chickens and effect on salmonella loads
CN110904002B (zh) * 2019-11-25 2022-04-29 天津大学 一种生物移除四环素类抗生素的方法
EP3842052A1 (de) 2019-12-23 2021-06-30 Senzyme GmbH Mittel und verfahren zur stabilisierung der darmflora und verbesserung der hygiene
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
GB9810276D0 (en) 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
FR2798291B1 (fr) * 1999-09-10 2005-01-14 Pasteur Institut Compositions acellulaires immunogenes et compositions acellulaires vaccinales contre bacillus anthracis
WO2002000232A2 (en) * 2000-06-26 2002-01-03 Maxygen, Inc. Methods and compositions for developing spore display systems for medicinal and industrial applications
GB0130789D0 (en) 2001-12-21 2002-02-06 King S College London Application of spores
WO2010006326A2 (en) * 2008-07-11 2010-01-14 Tufts University Methods and compositions for spore-based vaccines

Also Published As

Publication number Publication date
US20120237544A1 (en) 2012-09-20
EP2480241A1 (en) 2012-08-01
US8673311B2 (en) 2014-03-18
WO2011033275A1 (en) 2011-03-24
GB0916570D0 (en) 2009-10-28
CN102630163A (zh) 2012-08-08

Similar Documents

Publication Publication Date Title
CY1123958T1 (el) Μεθοδος παρασκευης παραγωγων και ενδιαμεσων καρβαμοϋλπυριδονης
MX351464B (es) El uso de un agonista del receptor 8 tipo toll para el tratamiento de enfermedades alérgicas.
TN2011000673A1 (en) Bace inhibitors
IN2012DN03883A (ja)
PH12014501273A1 (en) Intranasal dexmedetomidine compositions and methods of use thereof
MX2013001473A (es) Anticuerpos contra il-18r1 y usos de los mismos.
CA2798214C (en) Vaccine against beta-herpesvirus infection and use thereof
MX336323B (es) Anticuerpos de anti-poliubiquitina y metodos de uso.
UA107204C2 (uk) Протигрибкова композиція, що містить грибковий організм pythium oligandrum
TN2012000610A1 (en) Heterocyclic compounds, their preparation and their therapeutic application
IN2012DN03379A (ja)
MX2014009750A (es) Composiciones antifungicas para el tratamiento de piel y uñas.
MX2013007312A (es) Tratamiento con flama de substrato.
UA112760C2 (uk) Теобромін у комбінації з гвайфенезином для лікування кашлю
UA110332C2 (en) Use of 2,3-dihydroxypropyldodecanoate for treatment of seborrhea
MX349563B (es) Formulacion farmaceutica de fenofibrato nanonizado.
UA110626C2 (uk) Спосіб одержання пан-інгібіторів циклінзалежної кінази формули (i), а також проміжні продукти цього процесу одержання
WO2012065028A3 (en) Substituted tetracyclines
MX2013005825A (es) Benzoxazepinas como inhibidores de objetivo de rapamicina en mamiferos (mtor) y metodos de uso y fabricacion.
GR20120100608A (el) Προ-συναρμολογημενη εκθεσιακη κατασκευη
MX2013008559A (es) Derivados de leptina.
MX2013006526A (es) Dosis de los derivados de arilsulfonamida.
UA41922U (ru) Применение альтана как вещества с противолучевыми свойствами
UA94339C2 (ru) применение корвитина в качестве средства фригопротекторного действия
UA35660U (en) Use of antihomotoxic preparations as cytoprotectors